Skip to main content
Log in

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

A general data analysis technique estimates average population values of pharmacokinetic parameters and their interindividual variability from clinical pharmacokinetic data gathered during the routine care of patients. Several drug concentration values from each individual, along with dosage information and the values of other routinely assessed variables suffice for purposes of analysis. The Maximum Likelihood principle estimates underlying population values without the necessity for the intermediate estimation of individual parameter values. The approach is quite general, permitting the use of nonlinear statistical models with both fixed and random effects. Complex expressions involving physiological variables can be used to define the pharmacokinetic parameters. Thus, the relationship of physiological factors to parameter values can be assessed. The generality and appropriateness of the analysis technique are demonstrated by analysis of a set of data derived from 141 patients receiving the drug digoxin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L. B. Sheiner, B. Rosenberg, and K. L. Melmon. Modelling of individual pharmacokinetics for computer-aided drug dosage.Comp. Biomed. Res. 5:441–459 (1972).

    Article  Google Scholar 

  2. C. C. Peck, L. B. Sheiner, C. M. Martin, D. T. Combs, and K. L. Melmon. Computerassisted digoxin therapy.New Engl. J. Med. 289:441–446 (1973).

    Article  CAS  PubMed  Google Scholar 

  3. L. B. Sheiner, H. H. Halkin, C. C. Peck, B. Rosenberg, and K. L. Melmon. Improved computer-assisted digoxin therapy.Ann. Int. Med. 82:619–627 (1975).

    Article  CAS  PubMed  Google Scholar 

  4. J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, 1st ed., Drug Intelligence Publications, Hamilton, Ill., 1975, pp. 65–81.

    Google Scholar 

  5. W. L. Chiou and F. H. Hsu. A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogenous creatinine.Res. Comm. Chem. Pathol. Pharmacol. 10:315–330 (1975).

    CAS  Google Scholar 

  6. R. W. Jelliffe and S. M. Jelliffe. A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex, and weight.Math. Biosci. 14:17–24 (1972).

    Article  Google Scholar 

  7. R. J. Wonnacott and T. H. Wonnacott.Econometrics, Wiley, New York, 1970, pp. 34–38.

    Google Scholar 

  8. Y. Bard.Nonlinear Parameter Estimation, Academic Press, New York, 1974, pp. 61–71.

    Google Scholar 

  9. Y. Bard.Nonlinear Parameter Estimation, Academic Press, New York, p. 328.

  10. Y. Bard.Nonlinear Parameter Estimation, Academic Press, New York, pp. 170–216.

  11. H. Halkin, L. B. Sheiner, C. C. Peck, and K. L. Melmon. Determinants of the renal clearance of digoxin.Clin. Pharmacol. Ther. 17:385–394 (1975).

    CAS  PubMed  Google Scholar 

  12. T. W. Smith, V. P. Butler, Jr. and E. Haber. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.New Engl. J. Med. 281:1212–1216 (1969).

    Article  CAS  PubMed  Google Scholar 

  13. S. Oparil. Digitalis assay and its clinical application: Symposium on Cardiac Rhythm Disturbances. I.Med. Clin. N. Am. 60:193–207 (1976).

    CAS  PubMed  Google Scholar 

  14. R. H. Reuning, R. A. Sams, and R. E. Notari. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.J. Clin. Pharmacol. 13:127–141 (1973).

    CAS  Google Scholar 

  15. W. J. Jusko, S. J. Szefler, and A. L. Goldfarb. Pharmacokinetic design of digoxin dosage regimens in relation to renal function.J. Clin. Pharmacol. 15:94–104 (1974).

    Google Scholar 

  16. L. B. Sheiner, K. L. Melmon, and B. Rosenberg. Instructional goals for physicians in the use of blood level data-and the contribution of computers.Clin. Pharmacol. Ther. 16:260–271 (1974).

    CAS  PubMed  Google Scholar 

  17. J. R. Koup, W. J. Jusko, C. M. Elwood, and R. K. Kohli. Digoxin pharmacokinetics: Role of renal failure in dosage regimen design.Clin. Pharmacol. Ther. 18:9–21 (1975).

    CAS  PubMed  Google Scholar 

  18. A. A. MacKinney, Jr. G. H. Burnett, R. L. Conklin, and G. W. Wasson. Comparison of five radioimmunoassays and enzyme bioassay for measurement of digoxin in blood.Clin. Chem. 21:857–859 (1975).

    PubMed  Google Scholar 

  19. G. H. Burnett, R. L. Conklin, G. W. Wasson, and A. A. MacKinney. Variability of standard curves in radioimmunoassay of plasma digoxin.Clin. Chem. 19:725–726 (1973).

    CAS  PubMed  Google Scholar 

  20. J. G. Wagner, M. Christensen, E. Sakmar, D. Blair, J. D. Yates, P. W. Willin, III A. J. Sedman, and R. G. Stoll. Equivalence lack in digoxin plasma levels.J. Am. Med. Assoc. 224:199–204 (1973).

    Article  CAS  Google Scholar 

  21. D. H. Huffman and D. L. Azarnoff. Absorption of orally given digoxin preparations.J. Am. Med. Assoc. 222:957–960 (1972).

    Article  CAS  Google Scholar 

  22. D. H. Huffman, C. V. Manion, and D. L. Azarnoff. Intersubject variation in absorption of digoxin in normal volunteers.J. Pharm. Sci. 64:433–437 (1975).

    Article  CAS  PubMed  Google Scholar 

  23. J. L. Colaizzi. Digoxin.J. Am. Pharm. Assoc. NS15:43–46 (1975).

    Google Scholar 

  24. J. G. Wagner. Loading and maintenance doses of digoxin in patients with normal renal function and those with severely impaired renal function.J. Clin. Pharmacol. 14:329–338 (1974).

    Article  CAS  PubMed  Google Scholar 

  25. W. G. Kramer, R. P. Lewis, T. C. Cobb, W. F. Forester, Jr., J. A. Visconti, L. A. Wanke, H. G. Boxenbaum, and R. H. Reuning. Pharmacokinetics of digoxin: Comparison of a twoand a three-compartment model in man.Clin. Pharmacol. Ther. 18:9–21 (1975).

    Google Scholar 

  26. D. J. Greenblatt, D. W. Duhme, J. Koch-Weser, and T. W. Smith. Intravenous digoxin as a bioavailability standard: Slow infusion and rapid injection.Clin. Pharmacol. Ther. 15:510–513 (1973).

    Google Scholar 

  27. G. A. Ewy, G. G. Kapadia, L. Yao, M. Lullin, and F. I. Marcus. Digoxin metabolism in the elderly.Circulation 39:449–453 (1969).

    Article  CAS  PubMed  Google Scholar 

  28. R. W. Jelliffe. A mathematical analysis of digitalis kinetics in patients with normal and reduced renal function.Math. Biosci. 1:305–325 (1967).

    Article  CAS  Google Scholar 

  29. J. E. Doherty and W. H. Perkins. Studies with tritiated digoxin in human subjects after intravenous administration.Am. Heart J. 63:528–536 (1962).

    Article  CAS  PubMed  Google Scholar 

  30. E. Steiness. Renal tubular secretion of digoxin.Circulation 50:103–107 (1974).

    Article  CAS  PubMed  Google Scholar 

  31. J. E. Doherty, W. H. Perkins, J. Gammill, and J. Sherwood. Studies following intramuscular tritiated digoxin in human subjects.Am. J. Cardiol. 15:170–174 (1965).

    Article  CAS  PubMed  Google Scholar 

  32. L. A. Pagliaro and L. Z. Benet. Pharmacokinetic data.J. Pharmacokin. Biopharm. 3:333–381 (1975).

    Article  CAS  Google Scholar 

  33. J. E. Doherty, W. H. Perkins, M. C. Wilson, J. Gammill, C. Dodd, and J. Sherwood. Studies with tritiated digoxin in renal failure.Am. J. Med. 37:536–544 (1964).

    Article  CAS  PubMed  Google Scholar 

  34. P. M. Bloom, W. B. Nelp, and S. H. Tuell. Relationship of the excretion of tritiated digoxin to renal function.Am. J. Med. Sci. 251:133–144 (1966).

    Article  CAS  PubMed  Google Scholar 

  35. L. B. Sheiner, B. Rosenberg, V. V. Marathe, and C. C. Peck. Differences in serum digoxin concentrations between outpatients and inpatients: An effect of compliance?Clin. Pharmacol. Ther. 15:239–246 (1974).

    CAS  PubMed  Google Scholar 

  36. D. J. Sumner, A. J. Russell, and B. Whiting. Digoxin pharmacokinetics: Multicompartmental analysis and its clinical implications.Br. J. Clin. Pharmacol. 3:221–229 (1976).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. J. G. Wagner, J. D. Yates, P. W. Willis, E. Sakmar, and R. G. Stoll. Correlation of plasma levels of digoxin in cardiac patients with dose and measures of renal function.Clin. Pharmacol. Ther. 15:291–301 (1973).

    Google Scholar 

  38. FMFP, in System 360 Scientific Subroutine Package, Version III, Programmers Manual GH 20-0205-4, International Business Machines Corp. New York, 1970, p. 221.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by NIH Grant GM 16496.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheiner, L.B., Rosenberg, B. & Marathe, V.V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics 5, 445–479 (1977). https://doi.org/10.1007/BF01061728

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01061728

Key words

Navigation